John V. Duncia

5.8k total citations · 2 hit papers
52 papers, 4.2k citations indexed

About

John V. Duncia is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John V. Duncia has authored 52 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Organic Chemistry and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John V. Duncia's work include Renin-Angiotensin System Studies (15 papers), Receptor Mechanisms and Signaling (13 papers) and Hormonal Regulation and Hypertension (11 papers). John V. Duncia is often cited by papers focused on Renin-Angiotensin System Studies (15 papers), Receptor Mechanisms and Signaling (13 papers) and Hormonal Regulation and Hypertension (11 papers). John V. Duncia collaborates with scholars based in United States and Germany. John V. Duncia's co-authors include Andrew T. Chiu, David J. Carini, A.L. Johnson, Pancras C. Wong, Ruth R. Wexler, William A. Price, Pieter B.M.W.M. Timmermans, Joseph B. Santella, Michael E. Pierce and Dale E. McCall and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

John V. Duncia

51 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of angiotensin II receptor subtypes

1989 705 citations Andrew T. Chiu, William F. Herblin et al. Biochemical and Biophysical Research Communications profile →
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

1991 369 citations David J. Carini, John V. Duncia et al. Journal of Medicinal Chemistry profile →

Peers

John V. Duncia

CCM

EDM

CMN

A.L. Johnson United States

David J. Carini United States

Wolfgang Wienen Germany

Ruth R. Wexler United States

Andrew T. Chiu United States

Pancras C. Wong United States

Gary J. Grover United States

Edmund J. Sybertz United States

Paul G. Sleph United States

Charles S. Sweet United States

A.L. Johnson United States

John V. Duncia

2.2k ×0.9

CCM

2.1k ×1.0

1.1k ×0.9

EDM

984 ×1.0

578 ×1.0

CMN

Citations per year, relative to John V. Duncia John V. Duncia (= 1×) peers A.L. Johnson

Countries citing papers authored by John V. Duncia

Since Specialization

Citations

This map shows the geographic impact of John V. Duncia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Duncia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Duncia more than expected).

Fields of papers citing papers by John V. Duncia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John V. Duncia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Duncia. The network helps show where John V. Duncia may publish in the future.

Co-authorship network of co-authors of John V. Duncia

This figure shows the co-authorship network connecting the top 25 collaborators of John V. Duncia. A scholar is included among the top collaborators of John V. Duncia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John V. Duncia. John V. Duncia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cherney, Robert J., Ruowei Mo, Dayton T. Meyer, et al.. (2010). γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists. Bioorganic & Medicinal Chemistry Letters. 20(8). 2425–2430. 15 indexed citations

Gardner, Daniel S., Joseph B. Santella, Andrew J. Tebben, et al.. (2007). From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(2). 586–595. 9 indexed citations

Carini, David J., David D. Christ, John V. Duncia, & Michael E. Pierce. (2006). The Discovery and Development of Angiotensin II Antagonists. Kluwer Academic Publishers eBooks. 11. 29–56. 12 indexed citations

Wacker, Dean A., Joseph B. Santella, Daniel S. Gardner, et al.. (2002). CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 12(13). 1785–1789. 35 indexed citations

Duncia, John V., et al.. (1999). ChemInform Abstract: MEK Inhibitors: The Chemistry and Biological Activity of U0126, Its Analogues, and Cyclization Products.. ChemInform. 30(6). 2 indexed citations

Duncia, John V., Joseph B. Santella, C. Anne Higley, et al.. (1998). Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(7). 775–780. 32 indexed citations

Santella, Joseph B., John V. Duncia, Carol L. Ensinger, et al.. (1994). Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position.. Bioorganic & Medicinal Chemistry Letters. 4(18). 2235–2240. 14 indexed citations

Wong, Pancras C., John V. Duncia, Joseph B. Santella, et al.. (1994). EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes. European Journal of Pharmacology. 260(2-3). 261–264. 3 indexed citations

Duncia, John V., David J. Carini, Andrew T. Chiu, et al.. (1992). The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist. Medicinal Research Reviews. 12(2). 149–191. 173 indexed citations

10.

Wong, Pancras C., Andrew T. Chiu, John V. Duncia, et al.. (1992). Angiotensin II receptor antagonists and receptor subtypes. Trends in Endocrinology and Metabolism. 3(6). 211–217. 51 indexed citations

11.

Reilly, Thomas M., et al.. (1992). Monoclonal antibodies to the nonpeptide angiotensin II receptor antagonist, losartan. European Journal of Pharmacology Molecular Pharmacology. 226(2). 179–182. 5 indexed citations

12.

Wong, Pancras C., William A. Price, Andrew T. Chiu, et al.. (1991). In Vivo Pharmacology of DuP 753. American Journal of Hypertension. 4(4_Pt_2). 288S–298S. 99 indexed citations

13.

Timmermans, Pieter B.M.W.M., David J. Carini, Andrew T. Chiu, et al.. (1991). The Discovery of a New Class of Highly Specific Nonpeptide Angiotensin II Receptor Antagonists. American Journal of Hypertension. 4(4_Pt_2). 275S–281S. 46 indexed citations

14.

Chiu, Andrew T., Dale E. McCall, William A. Price, et al.. (1991). In Vitro Pharmacology of DuP 753. American Journal of Hypertension. 4(4_Pt_2). 282S–287S. 44 indexed citations

15.

Duncia, John V., Andrew T. Chiu, David J. Carini, et al.. (1990). The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. Journal of Medicinal Chemistry. 33(5). 1312–1329. 187 indexed citations

16.

Wong, Pancras C., William A. Price, Andrew T. Chiu, et al.. (1990). Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 211–217. 292 indexed citations

17.

Timmermans, Pieter B.M.W.M., David J. Carini, Andrew T. Chiu, et al.. (1990). Nonpeptide Angiotensin II Receptor Antagonists. American Journal of Hypertension. 3(8_Pt_1). 599–604. 51 indexed citations

18.

Chiu, Andrew T., William F. Herblin, Dale E. McCall, et al.. (1989). Identification of angiotensin II receptor subtypes. Biochemical and Biophysical Research Communications. 165(1). 196–203. 705 indexed citations breakdown →

19.

Wong, Pancras C., et al.. (1989). Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.. Journal of Pharmacology and Experimental Therapeutics. 250(2). 515–522. 17 indexed citations

20.

Chiu, Andrew T., Dale E. McCall, Tâm Nguyễn, et al.. (1989). Discrimination of angiotensin II receptor subtypes by dithiothreitol. European Journal of Pharmacology. 170(1-2). 117–118. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact